Printer Friendly

PFIZER BOARD APPROVES SALE OF 10.05 MILLION REMAINING MINERALS TECHNOLOGIES SHARES

 NEW YORK, Feb. 25 /PRNewswire/ -- Pfizer, Inc. (NYSE: PFE) announced today that its board of directors has authorized the sale of 10.05 million shares of common stock of Minerals Technologies Inc. Of this amount, 7.550 million will be sold through a secondary public offering pursuant to a registration statement expected to be filed with the Securities and Exchange Commission in mid-March and subject to market conditions at that time. This amount includes 750,000 shares reserved for underwriters' overallotment options.
 Pfizer and Minerals Technologies Inc. have agreed that subject to consummation of the offering, Minerals Technologies Inc. will purchase the remaining 2.5 million shares owned by Pfizer at the net offering price.
 Upon completion of the offering and repurchase, Pfizer will own 3.3 percent of the outstanding shares of Minerals Technologies Inc. and will own no shares if underwriters' overallotment options are exercised in full.
 NOTE: The securities described herein will be offered only by means of a prospectus. A registration statement relating to these securities will be filed with the Securities and Exchange Commission. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.
 -0- 2/25/93
 /CONTACT: Tony Biesada, 212-573-2055 or Rick Honey, 212-573-2051, both of Pfizer/
 (PFE)


CO: Pfizer Inc; Minerals Technologies Inc. ST: New York IN: MNG SU:

WB -- NY084 -- 0534 02/25/93 16:04 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 25, 1993
Words:238
Previous Article:MOODY'S RATES ITS FIRST CANADIAN HOUSING ISSUE
Next Article:NY TELEPHONE $200 MILLION 6.5 PERCENT NOTES RATED 'A+' BY FITCH -- FITCH FINANCIAL WIRE --
Topics:


Related Articles
PFIZER COMPLETES SALE OF PLAX INTERNATIONAL
PFIZER REPORTS NET INCOME GROWTH OF 14 PERCENT ON A 4 PERCENT SALES GAIN IN SECOND QUARTER
PFIZER'S REPORTED NET INCOME ROSE 8 PERCENT ON A 3 PERCENT SALES GAIN IN THE THIRD QUARTER
PFIZER COMPLETES SALE OF REMAINING INTEREST IN MINERALS TECHNOLOGIES INC.
PFIZER REPORTS SIX PERCENT SALES GAIN IN FIRST QUARTER; EARNINGS PER SHARE OF $1.01 ARE 15 PERCENT ABOVE 1992 EPS BEFORE ACCOUNTING CHANGES
PFIZER REPORTS EARNINGS PER SHARE GROWTH OF 20 PERCENT ON A 3 PERCENT SALES GAIN FOR THE SECOND QUARTER
Jean-Paul Valles Leaves Pfizer Board of Directors.
Pfizer Animal Health Agrees to Acquire Embrex, Inc., the Leader in 'In Ovo' Poultry Vaccine-Delivery Technology.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters